Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6453]

Researchers create framework to help determine timing of cancer mutations

Researchers create framework to help determine timing of cancer mutations

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued survival benefit

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued...

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

ASH 2020: Researchers test CRISPR in blood disorders and extend CAR-T therapy to benefit more patients

ASH 2020: Researchers test CRISPR in blood disorders and extend CAR-T therapy to benefit more patients

ASH 2020: Donor stem cell transplant shown to improve survival in older patients with MDS

ASH 2020: Donor stem cell transplant shown to improve survival in older patients with MDS

Huntsman Cancer Institute researchers identify promising drug combination for melanoma

Huntsman Cancer Institute researchers identify promising drug combination for melanoma

Genetically engineered T cells could lead to therapies for autoimmune diseases

Genetically engineered T cells could lead to therapies for autoimmune diseases

New map provides scientists with head start on how to destroy cancer-related enzymes

New map provides scientists with head start on how to destroy cancer-related enzymes

More from ecancer